In the future, the market space of pharmaceutical equipment industry will continue to open under the following trends

[ Market Analysis of Chemical Machinery Equipment Network ] With the end of the first half of 2021, major listed companies have begun to disclose their first-half results one after another
.
On the whole, over 60% of the companies are expected to perform well, and the companies with more outstanding performance mainly focus on the fields of chemical industry, medicine, integrated circuits, and equipment manufacturing
.
It is worth mentioning that many companies in the pharmaceutical equipment industry have performed well
.
For example, Xinlai Yingcai recently released the semi-annual performance forecast for 2021, and it is expected that the performance will increase in the same direction
.
During the reporting period, the company realized a net profit of 58 million yuan to 68 million yuan, an increase of 71.
82% to 101.
44% over the same period of the previous year; the profit of the same period last year was 33.
7572 million yuan
.

 

Although some pharmaceutical equipment companies have not released performance forecasts, the industry is generally optimistic about its development in the first half of the year, judging from the performance of the first quarter
.
Now that the time has come to the second half of the year, what will happen to the development of the pharmaceutical equipment industry? The author believes that under several major trends, the market space for pharmaceutical equipment is expected to continue to open up and gain more growth opportunities
.

 

With the continuous advancement of the new medical reform, the demand for pharmaceutical machine products will continue to expand
 

Previously, the "Opinions on Promoting the Normalization and Institutionalization of the Centralized Drug Procurement with Volume" issued by China clarified the normalization mechanism of the centralized drug procurement
.
Affected by this, the industry predicts that with the normalization of centralized procurement, the demand for pharmaceutical equipment by pharmaceutical companies will continue to grow, which will bring more development opportunities to the pharmaceutical equipment market
.

 

In fact, under the implementation of policies such as consistency evaluation and new version of GMP in recent years, in order to meet higher production requirements, the demand for pharmaceutical equipment has begun to soar
.
According to data, as early as 2011 to 2015, the annual output value of China's pharmaceutical equipment industry has increased from 8.
96 billion yuan in 2011 to 20.
19 billion yuan in 2015, breaking the 20 billion mark.
The compound growth rate reached 34%
.
In the future, according to this growth trend, coupled with the continuous deepening of a series of medical reform policies, the development space of the pharmaceutical equipment market will be even more impressive
.

 

　　Driven by digital technology, the transformation and upgrading of the pharmaceutical machine industry has accelerated
 

　　In recent years, as digitalization and intelligence have increasingly become emerging forces in the transformation and upgrading of China's medical system, its integration and innovation with the pharmaceutical equipment industry has also begun to become a new trend
.
This is mainly because the pharmaceutical equipment industry is a high-tech industry.
Its dependence on data and informatization, and the realization of better research, better manufacturing, better service, and improvement through big data and informatization The establishment of the public health system is particularly important
.
Therefore, through digital transformation and upgrading, it will become an important path to realize the expansion of the development space of the pharmaceutical equipment industry
.

 

　　It is worth noting that in recent years, the digital development of the pharmaceutical equipment industry has actually been supported by many policies
.
For example, the "14th Five-Year Plan for the Development of Intelligent Manufacturing" proposes that by 2025, the digitalization of manufacturing enterprises above designated size will be basically popularized, and the backbone enterprises in key industries will initially realize intelligent transformation
.
In addition, "Made in China 2025" also proposes to accelerate the integration and development of a new generation of information technology and manufacturing technology, take intelligent manufacturing as the main direction of in-depth integration of the two, and promote China's manufacturing model from "Made in China" to "Made in China".
"Intelligent Manufacturing" transformation
.
At present, with the continuous advancement of relevant policies, many domestic pharmaceutical equipment companies are actively investing in accelerating digital upgrading and transformation, and the results have begun to emerge, which are helping pharmaceutical companies to further improve management efficiency and reduce corporate costs.
, to boost the development of the entire pharmaceutical industry in better and higher quality
.

 

　　International layout brings more growth momentum to the pharmaceutical machine industry
 

　　According to data, as early as 2018, the average growth rate of the annual export delivery value of China's pharmaceutical equipment industry has exceeded 20%
.
It can be seen from the above that the acceleration of the internationalization process of domestic pharmaceutical equipment also reflects the improvement of domestic pharmaceutical equipment in terms of quality, technology, service, etc.
, and is gradually recognized by users in the international market
.
In this context, from the perspective of the industry, in the future, as domestic pharmaceutical equipment companies continue to actively deepen their international layout, they will surely shine in the international market
.
Bring more growth momentum to the industry
.

 

　　Original title: In the future, the market space of pharmaceutical equipment industry will continue to open under the following trends